METROPOLITAN LIFE INSURANCE CO/NY - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 135 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2021. The put-call ratio across all filers is 3.64 and the average weighting 0.4%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2021$237,113
-15.3%
24,048
-6.9%
0.00%0.0%
Q4 2020$279,932
+5.2%
25,8240.0%0.00%
-20.0%
Q3 2020$265,987
-43.4%
25,824
+14.7%
0.01%
-37.5%
Q2 2020$470,113
+141.9%
22,515
+13.2%
0.01%
+100.0%
Q1 2020$194,325
+14.5%
19,890
+35.0%
0.00%
+33.3%
Q4 2019$169,747
+50.8%
14,735
-28.7%
0.00%
+50.0%
Q3 2019$112,553
-54.2%
20,6520.0%0.00%
-50.0%
Q2 2019$245,552
+126.9%
20,6520.0%0.00%
+100.0%
Q1 2019$108,216
-10.6%
20,652
+3.2%
0.00%0.0%
Q3 2018$121,091
-99.9%
20,0150.0%0.00%0.0%
Q2 2018$106,080,00020,0150.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q1 2021
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 4,112,355$40,178,00034.81%
Versant Venture Management, LLC 7,068,233$69,056,636,00018.94%
ACUTA CAPITAL PARTNERS, LLC 1,704,500$16,653,0008.07%
Soleus Capital Management, L.P. 313,900$3,067,0003.57%
Ghost Tree Capital, LLC 1,305,500$12,755,0003.38%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$4,690,0002.97%
RTW INVESTMENTS, LP 6,631,627$64,791,0002.79%
VR Adviser, LLC 994,381$9,715,0002.63%
Avoro Capital Advisors LLC 7,150,000$69,856,0002.36%
RA Capital Management 7,272,714$71,054,0002.24%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders